The Neuropsychology of Huntington's Disease

被引:91
作者
Snowden, Julie S. [1 ,2 ]
机构
[1] Salford Royal NHS Trust, Greater Manchester Neurosci Ctr, Salford, Lancs, England
[2] Univ Manchester, Div Neurosci & Expt Psychol, Fac Biol Med & Hlth, Manchester, Lancs, England
关键词
Huntington's disease; Movement disorders; Subcortex; Basal ganglia; Congenital; genetic Disorders; Executive functions; QUALITY-OF-LIFE; EMOTION RECOGNITION; LONGITUDINAL EVALUATION; PSYCHIATRIC-DISORDERS; COGNITIVE PERFORMANCE; FUNCTIONAL DECLINE; EXECUTIVE FUNCTION; RECEPTOR-BINDING; MEMORY FUNCTION; GENE CARRIERS;
D O I
10.1093/arclin/acx086
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Huntington's disease is an inherited, degenerative brain disease, characterized by involuntary movements, cognitive disorder and neuropsychiatric change. Men and women are affected equally. Symptoms emerge at around 40 years, although there is wide variation. A rare juvenile form has onset in childhood or adolescence. The evolution of disease is insidious and structural and functional brain changes may be present more than a decade before symptoms and signs become manifest. The earliest site of pathology is the striatum and neuroimaging measures of striatal change correlate with neurological and cognitive markers of disease. Chorea and other aspects of the movement disorder are the most visible aspect of the disease. However, non-motor features have greatest affect on functional independence and quality of life, so require recognition and management. The evidence-base for non-pharmacological treatments in Huntington's disease is currently limited, but recent intervention studies are encouraging.
引用
收藏
页码:876 / 887
页数:12
相关论文
共 144 条
  • [1] Theory of mind and empathy in preclinical and clinical Huntington's disease
    Adjeroud, Najia
    Besnard, Jeremy
    El Massioui, Nicole
    Verny, Christophe
    Prudean, Adriana
    Scherer, Clarisse
    Gohier, Benedicte
    Bonneau, Dominique
    Allain, Philippe
    [J]. SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE, 2016, 11 (01) : 89 - 99
  • [2] Evidence for Deficits on Different Components of Theory of Mind in Huntington's Disease
    Allain, Philippe
    Havet-Thomassin, Valerie
    Verny, Christophe
    Gohier, Benedicte
    Lancelot, Celine
    Besnard, Jeremy
    Fasotti, Luciano
    Le Gall, Didier
    [J]. NEUROPSYCHOLOGY, 2011, 25 (06) : 741 - 751
  • [3] Andrews SC, 2015, NEURODEGENER DIS MAN, V5, P155, DOI [10.2217/NMT.14.58, 10.2217/nmt.14.58]
  • [4] Huntington's disease progression PET and clinical observations
    Andrews, TC
    Weeks, RA
    Turjanski, N
    Gunn, RN
    Watkins, LHA
    Sahakian, B
    Hodges, JR
    Rosser, AE
    Wood, NW
    Brooks, DJ
    [J]. BRAIN, 1999, 122 : 2353 - 2363
  • [5] [Anonymous], 2014, HUNTINGTONS DIS
  • [6] [Anonymous], HUNTINGTONS DIS
  • [7] [Anonymous], 2011, PLOS CURR-TREE LIFE, DOI [DOI 10.1371/CURRENTS.RRN1259, 10.1371/currents.RRN1259]
  • [8] Striatal glucose metabolism and dopamine D-2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease
    Antonini, A
    Leenders, KL
    Spiegel, R
    Meier, D
    Vontobel, P
    WeigellWeber, M
    SanchezPernaute, R
    deYebenez, JG
    Boesiger, P
    Weindl, A
    Maguire, RP
    [J]. BRAIN, 1996, 119 : 2085 - 2095
  • [9] Not on the face alone: perception of contextualized face expressions in Huntingtons disease
    Aviezer, Hillel
    Bentin, Shlomo
    Hassin, Ran R.
    Meschino, Wendy S.
    Kennedy, Jeanne
    Grewal, Sonya
    Esmail, Sherali
    Cohen, Sharon
    Moscovitch, Morris
    [J]. BRAIN, 2009, 132 : 1633 - 1644
  • [10] Onset and rate of striatal atrophy in preclinical Huntington disease
    Aylward, EH
    Sparks, BF
    Field, KM
    Yallapragada, V
    Shpritz, BD
    Rosenblatt, A
    Brandt, J
    Gourley, LM
    Liang, K
    Zhou, H
    Margolis, RL
    Ross, CA
    [J]. NEUROLOGY, 2004, 63 (01) : 66 - 72